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Aims Congenital heart defects (CHD) affect almost 1% of all live born children and the number of adults with CHD is
increasing. In families where CHD has occurred previously, estimates of recurrence risk, and the type of recurring
malformation are important for counselling and clinical decision-making, but the recurrence patterns in families are
poorly understood. We aimed to determine recurrence patterns, by investigating the co-occurrences of CHD in
1163 families with known malformations, comprising 3080 individuals with clinically confirmed diagnosis.
...................................................................................................................................................................................................
Methods and
results
We calculated rates of concordance and discordance for 41 specific types of malformations, observing a high vari-
ability in the rates of concordance and discordance. By calculating odds ratios for each of 1640 pairs of discordant
lesions observed between affected family members, we were able to identify 178 pairs of malformations that co-
occurred significantly more or less often than expected in families. The data show that distinct groups of cardiac
malformations co-occur in families, suggesting influence from underlying developmental mechanisms. Analysis of
human and mouse susceptibility genes showed that they were shared in 19% and 20% of pairs of co-occurring dis-
cordant malformations, respectively, but none of malformations that rarely co-occur, suggesting that a significant
proportion of co-occurring lesions in families is caused by overlapping susceptibility genes.
...................................................................................................................................................................................................
Conclusion Familial CHD follow specific patterns of recurrence, suggesting a strong influence from genetically regulated devel-
opmental mechanisms. Co-occurrence of malformations in families is caused by shared susceptibility genes.
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Introduction
Congenital heart defects (CHD) affect up to 8 of 1000 newborns,
making heart defects the most common congenital malformations.1,2
The defects comprise an assortment of structural malformations,
ranging from insignificant defects to complex life-threatening malfor-
mations, which require highly specialized medical care. The disorder
is genetically heterogeneous and can be caused by both single nucleo-
tide variants within genes as well as genomic copy number variants
which may affect several genes. The defects may present as isolated
malformations or in combination with other birth defects.3 Most pa-
tients survive into reproductive age, increasing the need for accurate
counselling regarding the risk for recurrence.4 The overall risk of re-
currence has been estimated to be from 3 to 9%,5–8 with variation
depending on the malformation in question, indicating that some mal-
formations are more heritable than others.6,9–13
Because of the varying severity of malformations, an important fac-
tor to consider when counselling families is the ability to predict the
type of lesion which might recur. Several studies have investigated
the patterns of recurrence of similar, or concordant, as opposed to
different, or discordant, types of malformation.5,10,14–19 It has previ-
ously been suggested that familial occurrence of certain malforma-
tions might be determined by cardiac developmental biology, and
that this is reflected in specific patterns of familial co-occurrence of
malformations. Conflicting results, however, have left this matter un-
resolved.15,18,20 A possible reason for the divergent results may be
that many previous studies have been based on small numbers
of affected pairs or that part of the malformations have not been
confirmed by diagnostic methods or inspection of medical
records.14,16,18,19
In this study, therefore, we sought to determine if familial co-
occurrence of lesions follows specific patterns by analysing their co-
occurrence in 1163 families, in which 3080 family members had a clin-
ically confirmed diagnosis. We calculated concordance and discord-
ance rates for 41 different types of lesion, and analysed the patterns
of discordant pairs within families in order to investigate if specific
constellations of malformations occur in families. We hypothesized
that shared susceptibility genes could mechanistically explain the
observed patterns of co-occurrence in families, testing our hypoth-
esis using data from mouse models and patients.
Methods
Study population
Data are based on 637 previously unpublished families and 526 families
from 187 peer reviewed papers (see Supplementary material online,
Table S1). Only clinically confirmed malformations were included in our
analyses. We excluded 197 individuals from our analyses due to unveri-
fied malformations. (additional information in Supplemental material on-
line). Patients were assigned International Pediatric Congenital Cardiac
Codes (IPCCCs, www.ipccc.net) (see Supplementary material online,
Table S2, Figure 1A).
Data analysis
Odds ratios (OR) were calculated as in Agresti et al.21 We counted the
number of unique pairs of diagnoses in a family as opposed to the number
of observed phenotype-pairs, as this number expands multiplicatively in
families with many affected individuals, ensuring that concordant and dis-
cordant events were only recorded between affected family members
(Figure 1B and C).
Grouping of the malformations was performed using hierarchical clus-
tering analysis according to Ward’s hierarchical agglomerative clustering
method.22 Significant differences in gender ratio were determined using
v2 testing. Difference between rate of first-degree relatedness (RFR) was
calculated using a two-sided Mann–Whitney U test. Significance of over-
lapping susceptibility genes was calculated using Fisher’s exact test and ad-
justed for multiple testing. Additional information regarding data analysis,
including a comparison of published and unpublished data and analysis for
negative selection bias, is provided in Supplementary methods.
Results
We included in the study a total of 1163 families with 3080 individuals
with verified CHD, of whom 1591 were male. Pedigrees are shown
in Supplementary material online, Figures S2 and S3. The average
number of individuals within the families was 8.8, with the average
number of individuals with verified diagnoses per family being 2.65
(±1.45). We observed 159 families (13.7%) with more than three af-
fected individuals, of which only 9 families had more than 10 affected
individuals. A total of 86 families (7.4%) were observed with affected
individuals in three or more generations.
We observed possible autosomal recessive, autosomal dominant
and X-linked inheritance patterns among the families, but for a large
fraction of the families several patterns of inheritance are possible,
due to the small family sizes. As deduced from apparent obligate car-
riers, we noticed reduced penetrance in 371 families (32%), suggest-
ing that this is a common phenomenon in familial congenital heart
disease. The most common malformations in the families were atrial
septal defects, followed by ventricular septal defects, bicuspid aortic
valve, aortic coarctation and persistent patency of the arterial duct,
these lesions affecting 685, 587, 387, 259 and 252 individuals, respect-
ively. We observed a significant male predominance for bicuspid aor-
tic valve and female predominance for atrial septal defects and
patency of the arterial duct (Figure 2).
Co-occurrence of pairs of malformations
in families
Family rates of concordance and discordance were calculated for
each malformation in the dataset (Figure 2). For most malformations,
the frequency of discordance was higher than the frequency of con-
cordance, suggesting that a high degree of discordance is a common
phenomenon in familial congenital cardiac disease. We observed a
few families with more than seven affected individuals, with these
families displaying a high degree of concordance, possibly caused by a
single mutation with high penetrance.
To compare rates of concordance and discordance with related-
ness in the families, we calculated the RFR (see Supplementary meth-
ods). The average RFR was significantly larger for concordant
compared with discordant pairs (0.81 vs. 0.68, respectively,
P= 0.011) (Figure 3), suggesting that concordance and relatedness is
correlated.
Odds ratios were calculated for 1640 pairs of diagnoses observed
in the data, with 178 pairs passing the confidence interval test (CI did
not span 1). Odds ratios for the most common (>25 observations in
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Figure 1 The number of unique pairs of diagnoses per family was tailed. The total number of times a pair was observed between families was used
in calculating the odds ratio for different pairs of diagnoses. (A) Example of a family with three affected individuals. (B) Possible pairs of diagnoses
observed between individuals. (C) A maximum of one unique pair was included per family. See Supplementary material online, Table S2 for
abbreviations.
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Figure 2 Gender ratio, concordance and discordance in 1163 congenital heart defects families. A family was considered to be concordant (green
bar) if all affected individuals shared the same diagnosis. A family was considered to be discordant (blue bar) if all affected individuals had different diag-
noses. If a family had family members that shared some of the diagnoses it was considered as both concordant and discordant (orange bar).
*Statistical significant differences.
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the data) discordant pairs with increased relative risk are shown in
Table 1. The full list of all 178 pairs is available in Supplementary ma-
terial online, Table S4.
We also found pairs of diagnoses with ORs <1, suggesting
decreased relative risk (Table 1). For example, the previous occur-
rence of an atrial septal defect in a family suggests a low likelihood of
the occurrence of either tetralogy of Fallot (OR = 0.26) or hypoplas-
tic left heart syndrome (OR = 0.35) in other family members.
Analysis of group-wise co-occurrence of
discordant malformations
We analysed the data for specific patterns of familial co-occurrence
of malformations using an unbiased, data-driven approach.
Hierarchical clustering analysis was used to group ORs calculated for
the 1640 pairs of diagnoses (Figure 4). This analysis revealed 10 major
groups with similar patterns of co-occurrence, confirming that spe-
cific groups of phenotypes co-occur within families. Our data also
suggest that certain malformations co-occur in more than one group,
for example discordant ventriculo-arterial connections and atrioven-
tricular septal defect. We compared our chosen groups of lesions
with the taxonomy proposed by Houyel et al.23 (see Supplementary
material online, Figure S10), revealing some differences. Outflow tract
malformations, for example, are split in three groups in our data,
compared with one large group in their taxonomy.
Sharing of susceptibility genes in
co-occurring malformations
To test whether the observed patterns of co-occurrence of discord-
ant malformations could be explained by shared susceptibility genes,
we identified sets of genes which cause cardiac malformations in
mice, corresponding to the cardiac lesions we observed within fami-
lies (see Supplementary material online, Table S5). The overlap be-
tween such deduced susceptibility genes was calculated for each
discordant pairs of 41 malformations, testing significance of the over-
lap using Fisher’s exact test, with correction for multiple testing (see
Supplementary material online, Figure S11). We found that 110 pairs
have a log-odds ratio (LOR) >_ 1 (marked yellow in Figure 4), suggest-
ing that they often co-occur in families, while 27 pairs have a
LOR <_ -1 (marked cyan in Figure 4), suggesting that they rarely co-
occur in families. We observed significant gene-overlap between 22
pairs (20.0%) out of the 110 discordant pairs with LOR >_ 1
(P= 1.69e-06, Fishers exact test) (Figure 5A). None of the 27 pairs of
Conc Disc
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Figure 3 Comparison of familial relatedness with concordance
and discordance. Relatedness is shown as a rate of first-degree re-
latedness, of which first-degree relatives have a rate of 1. The rate
decreases for more distant relatives.
.................................................................................................
Table 1 Odds ratios for pairs of malformations
Diagnosis A Diagnosis B OR CI # Pairs # Families
CHD with OR > 1a
ASD EbA 6.1 2.3–16 42 15
AVS BAV 7.4 4.8–11 165 59
AVSD PLSVC 6.6 3.2–13.4 30 13
AVSD SV 9.9 1.9–7.8 27 12
AVSD CMVb 123.7 15.8–969 46 11
BAV CoA 3 2.1–4.3 165 59
DORV VSD 3.4 1.3–8.7 32 12
Dxc PVS 6.2 3.2–12 39 17
Dxc TAPVR 12 5.4–25 29 11
Dxc HSA 23 10–54 25 11
IAA VSD 6.7 2.5–18 41 17
RAA TOF 3.6 1.7–7.9 29 10
TA VSD 4.2 2.2–8.1 76 29
TGA Dxc 6.1 3.0–12 31 13
TGA TAPVR 3.7 1.8–7.3 30 12
TGA SV 5.4 2.7–11 27 12
TGA PVA 3.1 1.5–6.2 27 11
CHD with OR < 1c
ASD BAV 0.21 0.14–0.34 77 22
ASD HLHS 0.35 0.21–0.57 52 19
ASD TOF 0.26 0.15–0.45 45 16
AVS VSD 0.21 0.12–0.38 32 13
AVS PDA 0.35 0.15–0.81 17 6
AVS TOF 0.17 0.05–0.53 6 3
AVS TGA 0.22 0.07–0.71 6 3
AVSD BAV 0.28 0.13–0.62 15 7
BAV VSD 0.23 0.15–0.34 65 28
BAV PDA 0.34 0.18–0.62 34 12
BAV PVS 0.17 0.07–0.39 15 6
BAV TOF 0.08 0.25–0.25 7 3
BAV TGA 0.11 0.03–0.34 8 3
CoA PVS 0.36 0.19–0.71 26 10
CoA TOF 0.10 0.03–0.31 6 3
HLHS TGA 0.33 0.13–0.82 13 5
HLHS TOF 0.09 0.02–0.37 4 2
See Supplementary material, Table S2 for abbreviations.
# Pairs, the total number of pairs; # Families, the number of families; CI, confi-
dence interval; OR, odds ratio.
aOdds ratios for pairs occurring more than 25 times between individuals.
bWe are aware that the correct anatomical term in this setting is ‘cleft left AV
valve’. Some CMV diagnoses may be AVSD.
cOdds ratios for pairs of diagnoses observed less often than expected from the
total number of occurrences in the data. The shown pairs are observed more
than 100 times without the other (A without B and B without A, respectively).
4 S.G. Ellesøe et al.
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malformations with LOR <_ -1 displayed significant gene overlap. We
observed similar results when using a smaller set of human suscepti-
bility genes (19.1% overlap, P= 0.00017) (Figure 5B).
Discussion
We have investigated the co-occurrence of cardiac malformations
presenting in families with congenital cardiac disease. The dataset dif-
fers significantly from population-based cohorts and registry-based
studies.1,7,24 It is not possible, therefore, to calculate recurrence risk
from our dataset. Our dataset, nonetheless, does permit high-
confidence calculation of co-occurrence ORs for a wide range of
lesions. Thus, we believe that the data could be helpful in the counsel-
ling of families in whom congenital cardiac disease has previously
been observed.
We observed a majority of small families, a low abundance of large
and multigenerational families, and a high frequency of reduced pene-
trance. We only included verified diagnoses, thus the number of af-
fected individuals per family is likely to be an underestimate and many
factors could potentially influence family size. Nevertheless, our data
contradict a monogenic mode of inheritance, favouring a polygenic
model. The abundance of families of small size is in agreement with
previous observations of higher recurrence risk in first degree rela-
tives when compared with second and third degree relatives.14,19
Our data suggest that families are predominantly discordant for
cardiac malformations in agreement with previous reports.5,10,16
Between one and two-fifth of families with occurrence of ventricular
and atrial septal defects, aortic coarctation, patency of the arterial
duct, and tetralogy of Fallot, nevertheless, display a high degree of
exact concordance. Exact concordance in a proportion of familial in-
cidence of tetralogy of Fallot was reported recently.14,19 Examples of
Figure 4 Patterns of co-occurrence of phenotypes in congenital heart defects families. The log-odds ratio (LOR) for 1640 pairs of malformations
is displayed as a heatmap. Only pairs occurring >_10 times in the dataset were included. To enhance readability only LOR values <_ -1 and >_1 are
shown. The data were grouped according to similarities in LOR using hierarchical cluster analysis. An anatomical term for each group is suggested on
the right. LVOTO, left ventricular outflow tract obstruction; RVOTO, right ventricular outflow tract obstruction; n.d., not determined. International
Pediatric Congenital Cardiac Code diagnoses are indicated in full and abbreviated.
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..predominantly concordant families segregating a single mutation in
NKX2-5, GATA4 or ACTC1 have also been published previously.25–28
Our data suggest correlation between concordance and related-
ness, but the large range of RFR in discordant pairs suggests that this
relationship is far from simple. Similar correlation was observed in a
recent study of familial tetralogy.14 An explanation for these observa-
tions may be that the number of different genetic modifiers of the dif-
ferent lesions increases with decreasing relatedness.
Specific patterns of co-occurrence of malformations were even
more pronounced when analysed by hierarchical cluster analysis,
which suggest that recurrence of defects follows specific patterns. In
this regard, our data support the notion that co-occurrence of de-
fects in families is determined by perturbations of specific develop-
mental mechanisms.15,20 This hypothesis has yet to be proven, but
recent evidence from genetic studies of unrelated patients suggests
that the lesions are caused by disturbances of the molecular net-
works which control cardiac development.29–32 We find it likely that
a similar mechanism is responsible for the group-wise co-occurrence
of malformations we observe in families. This suggests that genetic
defects inherited in families perturb a signalling network or develop-
mental mechanism responsible for formation of the particular cardiac
anatomical structures affected in the given patients.
Our data contradict the findings by Oyen et al.,18 who did not find
any distinct patterns of co-occurrence. Their study, however, was
performed on unvalidated registry data, which we recently reported
to have a false discovery rate of over one-third.33 Thus, false positive
familial occurrences in the registries could have confounded the ana-
lyses in that particular study. In addition, Oyen et al. classified their
malformations according to the system proposed by Botto et al.34
Their data were combined into 13 large groups of malformations be-
fore analysis, which may have concealed some patterns of co-
occurrences.
Clinical classification of congenital cardiac disease is challenging,
and several systems have been proposed. Most recently, Houyel
et al.23 proposed a classification system based on IPCCC. This system
is based on anatomy, echocardiography and criteria for clinical man-
agement, but not as yet on presumed developmental mechanisms.
The group-wise co-occurrence of malformations we observe in fami-
lies is partly in agreement with this taxonomy, but we also observe
differences. We propose that some of our observed differences may
indeed reflect an influence from underlying genetic or developmental
mechanisms.
We found a high frequency of discordance for atrioventricular sep-
tal defect, which may suggest that familial exact concordance of this
lesion is lower than previously reported.5,35 However, it is possible
that some of the diagnoses of clefting of the mitral valve may, in real-
ity, represent deficient atrioventricular septation. The hierarchical
clustering analysis suggested that familial occurrence follows two dis-
tinct patterns. In the first pattern, atrioventricular septal defects,
including clefting of the mitral valve, seem to be an isolated entity,
while a second pattern includes those with abnormalities in left–right
patterning, or the so-called ‘heterotaxy’. Our data, therefore, may
suggest that two distinctly different developmental mechanisms can
lead to deficient atrioventricular septation, and that it is very rare for
both of these mechanisms to occur in one family. This is of clinical im-
portance, since surgical correction of deficient atrioventricular sept-
ation when combined with abnormalities in left–right patterning is
usually more complicated than treatment of isolated defects.
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Figure 5 Overlap of deduced susceptibility genes between discordant phenotypes. Mouse (A) and human (B) susceptibility genes were identified
(numbers shown in bar chart) and malformations were analysed in pairs (M1 and M2, indicated on the y-axis).
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Clustering analysis grouped transposition of the great arteries to-
gether with other malformations involving the outflow tract. This
showed a strong association between transposition and abnormalities
in left–right patterning, suggesting a significant contribution to the fac-
tors producing the discordant ventriculo-arterial connections from
the developmental mechanism which also control asymmetry, an asso-
ciation reported previously by several groups.36–39
Double outlet right ventricle, closely related anatomically to dis-
cordant ventriculo-arterial connections when associated with a sub-
pulmonary interventricular communication, presented with a
different pattern of co-occurrence for that seen for the discordant
ventriculo-arterial connections. In our hierarchical clustering, double
outlet was grouped together with the discordant ventriculo-arterial
connections as outflow tract malformations, but the association be-
tween double outlet and lateralization abnormalities was weak com-
pared with the association noted for the overall combination of
discordant ventriculo-arterial connections and concordant atrioven-
tricular connections. This suggests that parts of the molecular mech-
anisms responsible for the overall groups of double outlet as
opposed to discordant ventriculo-arterial connections may be differ-
ent, or that our data were insufficient to detect the different pheno-
types making up the overall group of double outlet right ventricle. In
this regard, nonetheless, Peyvandi et al.19 did note differences in the
pattern of risk of recurrence between patients having transposition
as opposed to double outlet.
An aortic valve with two leaflets is found in up to 2% of the gen-
eral population. Such individuals account for up to half of those
with stenotic aortic valves, and may also carry a risk of bacterial
endocarditis and aortic dissection.40,41 A better understanding of
the aetiology of the bifoliate valve, therefore, is important. In our
analysis, we grouped the bicuspid valve with other malformations
involving the left ventricular outflow tract, finding that the bicus-
pid valve displays a high OR with both aortic coarctation (OR = 3)
and aortic valvar stenosis (OR = 7.4). In keeping with previous re-
ports,12,40 this suggests a common developmental mechanism.
We also observed negative associations with 11 different malfor-
mations, suggesting that familial occurrence of the bifoliate valve is
almost exclusively related to malformations involving the left ven-
tricular outflow tract.
We used data from mouse models and human disease genes to in-
vestigate if familial co-occurrence of malformations could be ex-
plained by the sharing of susceptibility genes. Translation of clinical
diagnoses into cardiac phenotypes observed in mice is not always
straightforward and an unknown part of the phenotypes reported in
the MGI database could well be misclassified. Both gene sets, none-
theless, showed that one-fifth of pairs of malformations have a signifi-
cant overlap of susceptibility genes. Since it is likely that many genes
associated with cardiac malformations in mice and humans remain to
be found, our findings could well be underestimated.
Similar phenotypic pleiotrophy has been observed in previous re-
ports of families segregating a known mutation with large effect, sup-
porting that a single gene can be associated with more than one type
of congenital cardiac malformation in a family.25,42,43
We have shown, therefore, that depending on the malformation,
co-occurrence of CHD in families is highly variable. In general, dis-
cordance can be expected twice as often as concordance. Familial
co-occurrence of discordant heart defects, however, follows distinct
patterns, which suggests an underlying developmental mechanism,
such as the sharing of susceptibility genes.
Supplementary material
Supplementary material is available at European Heart Journal online.
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